Susie Wyss used to inject herself daily with a medication for multiple sclerosis. “The injection hurt. It caused welts, ...

So when a new treatment becomes available, I inevitably have people that come in and want to know about it. So my patients keep me on my toes. My general approach to caring for those with MS is if ...

The treatment of multiple sclerosis (MS) has improved dramatically over the past two decades thanks to the advent of a second generation of immunomodulatory therapies. They have significantly ...

MS patients who achieve long-term stable disease on disease-modifying therapy may want to stop their medication for varying ...

[21] Of the intravenous therapies in development for MS, alemtuzumab (Campath) has reached the Phase III clinical trial stage. In a 36-month Phase II trial in patients with treatment-naive early ...

In MS, immune system cells mistakenly attack myelin. With stem cell treatment, doctors use chemotherapy to destroy these existing immune cells. Then, they introduce the new stem cells, which are ...

The FDA has advised health care professionals and patients with multiple sclerosis that treatment with glatiramer acetate is ...

During MS relapses, new symptoms may appear and existing symptoms ... or months until symptoms slowly improve, with or without treatment. Between RRMS relapses, you will experience periods of ...

Switching therapies is a common part of multiple sclerosis management and may be considered for several reasons.

Intranasal foralumab can modulate a number of immune cell types in people with non-active SPMS, developer Tiziana Life ...

You may experience periods of new or worsening symptoms ... Talk to your doctor to see which treatment option is best to help with your MS flares.